Back

Comparative effectiveness of lipid-lowering regimens for achieving ESC LDL-cholesterol targets in acute coronary syndrome: a real-world cohort analysis

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Implementing novel lipid‑lowering therapies Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Asimina Romiou

Sismanoglion Hospital, Marousi (Greece)

4 More presentations in this session

Presentation thumbnail
The nocebo effect in statin therapy: clinical implications for adherence and cardiovascular outcomes
Doctor M. Sargsyan (Yerevan, AM)
Abstract Slides Video
Presentation thumbnail
Variability in lipoprotein(a) measurements in ODYSSEY OUTCOMES: is one-and-done testing sufficient?
Professor P. Steg (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Nationwide implementation of PCSK9--targeted therapies after myocardial infarction and ischemic stroke: structural barriers and disparities in a universal healthcare system
Assistant Professor P. Sedova (Brno, CZ)
Abstract Slides Video
Presentation thumbnail
Atorvastatin for prevention of chemotherapy-induced cardiotoxicity: a 5-year propensity-matched cohort study of 800 patients
Doctor R. Rascon Sabido (Veracruz, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Implementing novel lipid‑lowering therapies

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Sustained combination lipid-lowering therapy determines durability of LDL-C <55 mg/dL after ACS: a structured implementation study (2022–2026)
30 August 2026
thumbnail
Congress Presentation
Upfront combination lipid-lowering therapy in statin-naive acute coronary syndrome patients with high admission LDL-C: real-world support for the 2025 ESC dyslipidaemias guidelines
28 August 2026
thumbnail
Congress Presentation
Lipid assessment and target attainment in acute coronary syndrome: a 10-year comparative review in a UK tertiary centre.
28 August 2026
thumbnail
Congress Presentation
Acute LDL-C reduction post acute coronary syndrome: strike early and strike strong: from evidence to clinical practice
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources